Respiratory

A once-daily oral therapy targeting neutrophilic inflammation has shown promise in reducing exacerbations in patients with bronchiectasis.

Including imaging and symptom-based data in COPD diagnosis captures patients with high-risk disease who would otherwise be overlooked by spirometry alone.

Repeated exposure to antibiotics during the perinatal period in very low birth weight preterm infants is associated with impaired lung function by early school age.

A new study identifies airway eosinophilia as a distinct, corticosteroid-responsive subtype of COPD, marked by heightened type 2 inflammation and gene expression changes.

A new Phase III trial has strengthened the evidence supporting cytisinicline as an effective and well-tolerated medication for smoking cessation.

Rare genetic variants and common polygenic risk scores independently influence survival in idiopathic pulmonary fibrosis.

Discover how HSK31858 could transform bronchiectasis treatment by reducing flare-ups – read more about the latest trial results.

New data reveal that acute pulmonary embolism, though rare in children and adolescents, carries a significant risk of death.